Clinical Research Directory
Browse clinical research sites, groups, and studies.
Covid-19 and Influenza Oral Vaccine Study
Sponsor: Vaxine Pty Ltd
Summary
The purpose of the current study is to assess the effectiveness of protein-based COVID-19 or influenza vaccines when given individually or together via oral/ sublingual mucosal route instead of intramuscular delivery. The comparator will be a seasonal influenza vaccine which will also be administered with Advax-CpG adjuvant via the oral route. This study will use a cross-over design and everyone in the study will over a space of about 4 months receive both the COVID-19 and influenza vaccines.
Official title: A Binded, Randomised, Controlled Cross-over Trial to Assess the Safety and Efficacy of Mucosal Covid-19 and Influenza Vaccines
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-05-01
Completion Date
2026-12-31
Last Updated
2025-09-17
Healthy Volunteers
Yes
Conditions
Interventions
Covid-19 vaccine
Recombinant SARS-CoV-2 spike protein with Advax-CpG55.2 adjuvant
Influenza vaccine
Inactivated seasonal influenza vaccine with Advax-CpG55.2 adjuvant
Locations (1)
ARASMI
Adelaide, South Australia, Australia